BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: £0 M
• Last 3 months FTD volume: £0.66 M
• Last 12 months FTD volume: £4.86 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	£24.58 M	£0.24 B	🇺🇸 USA
GSK plc GSK	£48.95 M	£0.36 B	🇬🇧 UK
Sarepta Therapeutics SRPT	£3.82 M	£21.38 M	🇺🇸 USA
Repligen RGEN	£6.47 M	£21.79 M	🇺🇸 USA
Novavax NVAX	£15.56 M	£63.4 M	🇺🇸 USA
Celldex Therapeutics CLDX	£6.56 M	£10.98 M	🇺🇸 USA
NanoViricides NNVC	£1.32 M	£4.28 M	🇺🇸 USA
Cel-Sci CVM	N/A	£0.37 M	🇺🇸 USA
Emergent BioSolutions EBS	£0.66 M	£4.47 M	🇺🇸 USA